Deux cas de dermatose acantholytique sous vémurafénib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Deux cas de dermatose acantholytique sous vémurafénib

Published:2014-11 Issue:11 Volume:141 Page:689-693
ISSN:0151-9638
Container-title:Annales de Dermatologie et de Vénéréologie
language:fr
Short-container-title:Annales de Dermatologie et de Vénéréologie

Author:

Sabatier-Vincent M.,Charles J.,Pinel N.,Challende I.,Claeys A.,Leccia M.-T.

Publisher

Elsevier BV

Subject

Dermatology

Reference21 articles.

1. New drugs in melanoma: it's a whole new world;Eggermont;Eur J Cancer,2011

2. Improved survival with vemurafenib in melanoma with BRAF-V600E mutation;Chapman;N Engl J Med,2011

3. RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors;Su;N Engl J Med,2012

4. Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma;Anforth;Br J Dermatol,2012

5. Prospective study of cutaneous side effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients;Boussemart;Ann Oncol,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Grover Disease Associated With Chemotherapy: Review of Potential Pathophysiology, Current Treatments, and Future Directions;Journal of Drugs in Dermatology;2020-10-01

2. Vemurafenib;Reactions Weekly;2014-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP